District Of Columbia is currently home to 920 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Washington, Washington, D.C., Washington DC and Washington, Dc. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Study of Stereotactic Radiotherapy for Breast Cancer
NCT03043794
Recruiting
This is a Phase II trial of preoperative stereotactic radiation to the breast for low risk breast cancer.
Gender:
Female
Ages:
Between 50 years and 100 years
Trial Updated:
05/30/2023
Locations: Sibley Memorial Hospital, Washington, District of Columbia
Conditions: Breast Cancer
Register for Updates
Transcatheter Aortic Prosthesis Function: A Long-term Follow-up Study
NCT03002272
Recruiting
In this observational study, the investigators will enroll subjects who underwent TAVR or SAVR more than 3 years ago. Clinical and procedural data from the implant/surgery will be collected, alongside clinical and echocardiographic data from subsequent follow-up visits.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/25/2023
Locations: Washington Hospital Center, Washington, District of Columbia
Conditions: Aortic Valve Replacement
Register for Updates
Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies
NCT04002674
Recruiting
Dementia with Lewy Bodies (DLB) is an alphasynucleinopathy and the second most common form of dementia in the elderly. DLB shares striking neuropathological and clinical similarities with both Parkinson's disease (PD) and Alzheimer's disease (AD). Nilotinib (Tasigna®, AMN107, Novartis, Switzerland) is approved by the FDA and is well tolerated for CML treatment at oral doses of 600-800mg daily. The Investigators propose to perform a phase II randomized, double blinded, placebo controlled study to... Read More
Gender:
All
Ages:
Between 25 years and 90 years
Trial Updated:
05/11/2023
Locations: MedStar Georgetown University Hospital, Washington, District of Columbia
Conditions: Dementia With Lewy Bodies
Register for Updates
Helping Toddlers and Parents Together
NCT04864808
Recruiting
Using stakeholder feedback (i.e., behavioral health providers & caregivers), the goal of this study is to develop a behavioral parenting program that focuses on both parent mental health and parenting for parents of toddlers (12-35 months old). Using a deployment focused intervention model, this study will : (1) develop an early parenting intervention for parents of at-risk toddlers which integrates a focus on parent mental health with evidence-based behavioral parenting strategies, and (2) exam... Read More
Gender:
All
Ages:
Between 12 months and 55 years
Trial Updated:
05/09/2023
Locations: Children's National Medical Center, Washington, District of Columbia
Conditions: ADHD, Parenting
Register for Updates
EndoBarrier System Pivotal Trial(Rev E v2)
NCT04101669
Recruiting
A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Evaluating the EndoBarrier System for Glycemic Improvement in Patients with Inadequately Controlled Type 2 Diabetes and Obesity, the STEP-1 Study. A multi-center, double-blinded, randomized, sham-controlled trial to evaluate the safety and effectiveness of the EndoBarrier System plus moderate intensity lifestyle and dietary counseling compliant with 2019 ADA Standard of Care as compared to a sham control receiving moderate intensity... Read More
Gender:
All
Ages:
Between 30 years and 65 years
Trial Updated:
05/09/2023
Locations: MedStar Health Research Institute, Washington, District of Columbia
Conditions: Diabetes type2, Obesity
Register for Updates
Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)
NCT05268094
Recruiting
COMPASS is a prospective multicenter randomized interventional trial. Participants with ductal-dependent pulmonary blood flow will be randomized to receive either a systemic-to-pulmonary artery shunt or ductal artery stent. Block randomization will be performed by center and by single vs. two ventricle status. Participants will be followed through the first year of life.
Gender:
All
Ages:
Between 1 day and 30 days
Trial Updated:
04/12/2023
Locations: Children's National Medical Center, Washington, District of Columbia
Conditions: Congenital Heart Disease in Children
Register for Updates
Vibroacoustic Study of Lung Development in Newborn Infants
NCT05827250
Recruiting
Investigators hypothesize that premature newborns with poor cardiopulmonary performance have higher morbidities and poorer physical and cognitive developmental outcomes. Investigators further hypothesize that audible sounds combined with novel inaudible vibrations above and below human perception interpreted with transparent and auditable AI algorithms can detect and identify early gas and fluid movement anomalies not uncovered by conventional tools in an non-invasive, easy, fast, and low cost... Read More
Gender:
All
Ages:
Between 0 years and 2 years
Trial Updated:
04/11/2023
Locations: Medstar Georgetown University Hospital, Washington, District of Columbia
Conditions: Prematurity, Premature Birth, Premature Lungs, Prematurity; Extreme
Register for Updates
PedBot Ankle Rehablitation
NCT05825508
Recruiting
The primary objective of the study is to determine engagement with use and adherence to a home exercise program with our PedBotHome ankle rehabilitation device. We will place the device in the home for 90 days and consider the study a success if used for at least 30 minutes a day for at least 3 days a week during this period.
Gender:
All
Ages:
Between 5 years and 18 years
Trial Updated:
04/11/2023
Locations: Children's National Health System, Washington, District of Columbia
Conditions: Cerebral Palsy
Register for Updates
Blue Light Cystoscopy With Cysview® Registry
NCT02660645
Recruiting
Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/27/2023
Locations: Sibley Memorial Hospital, Washington, District of Columbia
Conditions: Bladder Cancer
Register for Updates
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183
Recruiting
Post-marketing safety data on patients treated and untreated with eculizumab or ravulizumab.
Gender:
All
Ages:
All
Trial Updated:
03/23/2023
Locations: Clinical Trial Site, Washington, District of Columbia
Conditions: Atypical Hemolytic-Uremic Syndrome
Register for Updates
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
NCT02205762
Recruiting
The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age < 18 years).
Gender:
All
Ages:
18 years and below
Trial Updated:
03/21/2023
Locations: Children's National Medical Center, Washington, District of Columbia
Conditions: Langerhans Cell Histiocytosis
Register for Updates
Evaluating the Effectiveness of a Cognitive Behavioral Intervention (CBI)
NCT05782348
Recruiting
This is a Phase III, randomized, one-center, three arm parallel group, open label and single blind clinical study to evaluate the effectiveness of a cognitive behavioral intervention (CBI) adjunctive to a smart powered toothbrush on the oral health of adolescents.
Gender:
All
Ages:
Between 14 years and 17 years
Trial Updated:
03/13/2023
Locations: Friendship Public Charter School, Washington, District of Columbia
Conditions: Adolescent Behavior, Dental Plaque, Gingivitis, Cognitive Change
Register for Updates